Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 December 2024

News Healthcare & Pharma General Updates

Date: 13th Dec, 2024 Source: European Medicines Agency (EMA) Country: European Union Original Source

Brief

"On 13/12/2024, the European Medicines Agency (EMA) issued an update regarding Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 December 2024. The CHMP recommended approval for 17 new medicines, including Andembry and Beyonttra, which are intended to treat hereditary angioedema and transthyretin amyloidosis, respectively."

This content is restricted.

Highlights content goes here...

This content is restricted.

European Medicines Agency (EMA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 December 2024

Brief

European Medicines Agency (EMA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 December 2024

Brief

European Medicines Agency (EMA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.